Psychedelics' promise: Potential breakthrough in mental health therapy
Recent studies suggest that psychedelics may support the treatment of mental and neurological disorders. It turns out that these substances improve the brain's neuroplasticity and positively affect the treatment of anxiety and post-traumatic stress disorder (PTSD). Will we be able to buy LSD or psilocybin at the pharmacy in the future?
Psychedelics can have therapeutic effects, but only under certain conditions. In recent years, more and more studies indicate that these substances can support the treatment of depression, PTSD, anxiety, or addictions, especially when used in combination with psychotherapy.
A new approach to therapy
Researchers from the University of Michigan discovered that a single administration of psychedelics significantly improves the cognitive functions of the brain. The results of these studies may have a significant impact on psychiatry and modern therapeutic methods that could support patients with various conditions, including those who have not been helped by traditional medications.
The study's results may revolutionize psychiatry by offering new therapeutic methods for patients who have not benefited from conventional pharmacology. Research on psychedelics began as early as the 1950s, sparking great interest among scientists. Substances such as LSD and psilocybin were analyzed for their potential application in treating depression, alcoholism, anxiety, and as a support in psychotherapy. The results of many of these early studies were promising, as patients reported significant changes in self-perception and a reduction in psychological symptoms. Despite these positive results, these substances began to be used outside scientific control. The widespread use of psychoactive substances led to strong political and social opposition, eventually resulting in their prohibition.
The journal "Psychedelics" published studies showing that mice given a single dose of 25CN-NBOH achieved better results in tasks related to learning reversal compared to the control group animals. Importantly, these positive effects were visible even two to three weeks after the substance was administered.
Long-term benefits
Cellular analyses confirm that psychedelics modify the structure of the prefrontal cortex, which translates to better brain function. Researchers emphasize that the benefits may persist long after the direct effects of the drug have worn off.
The research provides evidence of the therapeutic effects of psychedelics and may be a step forward in treating treatment-resistant diseases. Therapies using them can produce effects lasting several months.
